Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDX NASDAQ:MOTS NASDAQ:SINT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.67-4.3%$1.90$1.65▼$16.68$1.73M0.7222,647 shs7,147 shsMOTSMotus GI$0.00$0.00▼$0.10$1K0.812,656 shsN/ASINTSintx Technologies$2.27-5.4%$2.56$1.99▼$6.78$9.34M0.6140,487 shs30,165 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics0.00%-5.38%-15.01%-37.45%-75.58%MOTSMotus GI0.00%0.00%0.00%-50.00%-66.67%SINTSintx Technologies0.00%-3.40%-15.30%-25.33%-34.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.67-4.3%$1.90$1.65▼$16.68$1.73M0.7222,647 shs7,147 shsMOTSMotus GI$0.00$0.00▼$0.10$1K0.812,656 shsN/ASINTSintx Technologies$2.27-5.4%$2.56$1.99▼$6.78$9.34M0.6140,487 shs30,165 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics0.00%-5.38%-15.01%-37.45%-75.58%MOTSMotus GI0.00%0.00%0.00%-50.00%-66.67%SINTSintx Technologies0.00%-3.40%-15.30%-25.33%-34.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 1.00SellN/AN/AMOTSMotus GI 0.00N/AN/AN/ASINTSintx Technologies 2.33Hold$11.00384.58% UpsideCurrent Analyst Ratings BreakdownLatest SINT, BJDX, and MOTS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026SINTSintx Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026SINTSintx Technologies HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$10.004/8/2026SINTSintx Technologies Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $12.003/27/2026BJDXBluejay Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay DiagnosticsN/AN/AN/AN/A$4.04 per shareN/AMOTSMotus GI$319K0.00N/AN/A$1.74 per share0.00SINTSintx Technologies$729K12.84N/AN/A$0.80 per share2.84Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$6.85M-$11.63N/AN/AN/AN/A-144.27%-115.00%N/AMOTSMotus GI-$12.87M-$14.69N/AN/AN/AN/AN/AN/AN/ASINTSintx Technologies-$10.36M-$5.66N/AN/AN/A-1,018.08%-242.76%-99.86%5/21/2026 (Estimated)Latest SINT, BJDX, and MOTS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2026Q1 2026SINTSintx Technologies-$0.66-$0.70-$0.04-$0.70$0.30 million$0.38 million5/7/2026Q1 2026BJDXBluejay DiagnosticsN/A-$1.95N/A-$1.95N/AN/A3/6/2026Q4 2025BJDXBluejay DiagnosticsN/A$3.23N/A$3.23N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A2.814.88MOTSMotus GIN/AN/AN/ASINTSintx TechnologiesN/A1.511.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%MOTSMotus GI20.06%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%MOTSMotus GI0.34%SINTSintx Technologies4.08%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.03 million1.03 millionNot OptionableMOTSMotus GI305.77 million5.75 millionNot OptionableSINTSintx Technologies404.12 million3.95 millionNot OptionableSINT, BJDX, and MOTS HeadlinesRecent News About These CompaniesSINTX Technologies to Present at the LD Micro Invitational XVI Conference2 hours ago | newsfilecorp.comNSintx Technologies (SINT) Projected to Post Quarterly Earnings on FridayMay 8, 2026 | americanbankingnews.comSintx Technologies (SINT) price target decreased by 25.00% to 12.24April 15, 2026 | msn.comHC Wainwright & Co. initiates coverage of Sintx Technologies (SINT) with buy recommendationApril 13, 2026 | msn.comSINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial ExecutionMarch 23, 2026 | globenewswire.comSINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle ImplantMarch 19, 2026 | globenewswire.comSintx Technologies (NASDAQ:SINT) Director Purchases $21,848.60 in StockMarch 11, 2026 | insidertrades.comSINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterialsMarch 2, 2026 | voxelmatters.comVSINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial PlatformsFebruary 18, 2026 | globenewswire.comSINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5January 29, 2026 | markets.businessinsider.comSINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5January 29, 2026 | globenewswire.comSintx Technologies (SINT) price target decreased by 36.00% to 16.32December 21, 2025 | msn.comInsider Buying: Sintx Technologies (NASDAQ:SINT) CIO Buys 8,200 Shares of StockDecember 10, 2025 | insidertrades.comSintx Technologies (NASDAQ:SINT) CIO Gregg Honigblum Acquires 65,000 SharesDecember 9, 2025 | insidertrades.comAscendiant Capital maintains Sintx Technologies (SINT) buy recommendationDecember 8, 2025 | msn.comSINTX Technologies to Participate in Sidoti & Company Investor ConferenceDecember 8, 2025 | markets.businessinsider.comSINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific ImplantsDecember 1, 2025 | globenewswire.comSINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational EfficienciesNovember 13, 2025 | markets.businessinsider.comInsider Buying: Sintx Technologies (NASDAQ:SINT) CIO Acquires 10,000 Shares of StockNovember 11, 2025 | insidertrades.comSINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge SystemNovember 3, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSINT, BJDX, and MOTS Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.67 -0.08 (-4.30%) Closing price 05/15/2026 03:59 PM EasternExtended Trading$1.63 -0.04 (-2.40%) As of 05/15/2026 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Motus GI NASDAQ:MOTSMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Sintx Technologies NASDAQ:SINT$2.27 -0.13 (-5.42%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$2.34 +0.07 (+2.91%) As of 05/15/2026 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In Robinhood, SoFi, and Webull Are Telling Very Different Stories Viking Sails to All-Time Highs—Fundamentals Signal More to Come Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
